Evaluation and management of well-appearing febrile infants 8 to 60 days old

SUBCOMMITTEE ON FEBRILE INFANTS

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

This guideline addresses the evaluation and management of wellappearing, term infants, 8 to 60 days of age, with fever ≥38.0°C. Exclusions are noted. After a commissioned evidence-based review by the Agency for Healthcare Research and Quality, an additional extensive and ongoing review of the literature, and supplemental data from published, peer-reviewed studies provided by active investigators, 21 key action statements were derived. For each key action statement, the quality of evidence and benefit-harm relationship were assessed and graded to determine the strength of recommendations. When appropriate, parents' values and preferences should be incorporated as part of shared decision-making. For diagnostic testing, the committee has attempted to develop numbers needed to test, and for antimicrobial administration, the committee provided numbers needed to treat. Three algorithms summarize the recommendations for infants 8 to 21 days of age, 22 to 28 days of age, and 29 to 60 days of age. The recommendations in this guideline do not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.

Original languageEnglish (US)
Article numbere2021052228
JournalPediatrics
Volume148
Issue number2
DOIs
StatePublished - Aug 1 2021

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Evaluation and management of well-appearing febrile infants 8 to 60 days old'. Together they form a unique fingerprint.

Cite this